Virginia Governor Blocks Initiative to Reduce Prescription Drug Costs
In a notable decision, Virginia's governor has vetoed legislation that sought to establish an advisory panel aimed at lowering prescription drug prices, impacting potential savings for residents.
Breakthrough in Drug Development: New Molecules from Sea Sponge Bacteria
Researchers at Florida State University have made significant strides in drug discovery by synthesizing new molecules from bacteria sourced from a Pacific Ocean sea sponge, which could aid in developing treatments for rare cancers.
Study Reveals Gaps in Conflict-of-Interest Policies Among Canadian Medical Societies
A recent analysis indicates that most Canadian medical societies do not have adequate conflict-of-interest policies, with many existing policies being fragmented and limited in scope.
Maryland Sets Price Cap on Ozempic Amid National Drug Affordability Efforts
In a notable move, Maryland's State Affordability Board has established a price cap on Ozempic, joining nine other states exploring similar affordability measures for prescription drugs.
TrumpRx Expands with Help from Amazon, GoodRx, and Mark Cuban
The Trump administration has announced a significant expansion of its drug discount platform, TrumpRx, adding 600 generic medications through partnerships with major online pharmacies.
Innovative Microneedle Patch Vaccine Aims to Transform Agricultural Practices
Researchers at the University of Connecticut have developed a microneedle patch vaccine that could address significant challenges in agricultural vaccine distribution.
Experts Consider Testing Unapproved Ebola Vaccine Amid Outbreak in DRC
As the Ebola outbreak continues in the Democratic Republic of the Congo, experts are contemplating the testing of an unapproved vaccine, given the lack of approved options.
AstraZeneca Secures FDA Approval for New Hypertension Treatment
AstraZeneca has received FDA approval for its hypertension medication, marking a significant development in the biotech sector amid ongoing discussions about FDA leadership and other industry news.
Supreme Court Dismisses Challenge to Medicare Drug Price Negotiation
The Supreme Court's decision could complicate ongoing lawsuits from pharmaceutical companies regarding drug price negotiations.
MV Hondius Arrives in Rotterdam Amid Hantavirus Concerns
The MV Hondius has docked in Rotterdam for disinfection as authorities prepare to quarantine the remaining crew following a hantavirus outbreak affecting multiple countries.
U.K. Advocacy Groups Consider Legal Action Against Pharma Trade Agreement
Two advocacy groups are urging the U.K. government to reconsider regulations tied to a U.S. pharma trade deal, threatening legal action if changes are not made.
GMC Driver Questions $15,000 Engine Repair Quote After Seeking Second Opinion
A GMC driver was stunned to receive a $15,000 quote for engine replacement, leading him to seek a second opinion that offered a more affordable solution.
Concerns Grow as FDA Drug Center Head Tracy Beth Høeg Resigns
Tracy Beth Høeg's resignation from the FDA's drug center follows the recent departure of Commissioner Marty Makary, highlighting a troubling leadership gap within the agency.
Understanding Federal Vaccine Injury Compensation Programs: Key Insights
This editorial explores the federal government's Vaccine Injury Compensation Program and the Countermeasures Injury Compensation Program, highlighting their history and ongoing policy discussions.
U.S. Urges Germany to Reconsider Drug Pricing Strategies Amid Ongoing FDA Changes
In the latest Pharmalittle update, the U.S. is applying pressure on Germany regarding drug pricing policies, alongside notable changes within the FDA and developments in biotech clinical trials.
Justice Department Raises Concerns Over Admissions Practices at Yale and UCLA Medical Schools
The DOJ has accused Yale and UCLA medical schools of potentially discriminatory admissions practices against white and Asian applicants, highlighting ongoing debates about equity in education.
BeOne Secures FDA Approval in Lymphoma Treatment
In a significant development, BeOne has received FDA approval for its lymphoma treatment. Meanwhile, Regenxbio is making strides in Duchenne gene therapy, among other biotech updates.
Pharmalittle: Highlights from Recent Developments in Medicine
Biogen has shared mixed findings from a mid-stage trial for an Alzheimer’s treatment aimed at the tau protein, amidst other industry news.
Princess Catherine's First International Trip Post-Cancer Remission
Catherine, Princess of Wales, embarked on her first official overseas journey to Reggio Emilia, Italy, following her announcement of cancer remission.
Decline in U.S. Overdose Deaths in 2025 Raises Concerns Over Future Policies
Preliminary government data indicates a 14% decrease in drug overdose deaths in 2025, with around 70,000 fatalities reported. However, experts express concern over potential policy and drug supply changes.